Adverum Biotechnologies
ADVM
$8.04
Share price
-2.55%
Change (1 day)
957.89%
Change (1 year)
Adverum Biotechnologies (ADVM) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $89.54 M
According to Adverum Biotechnologies 's latest financial reports the company's total liabilities are $89.54 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Adverum Biotechnologies - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 2.68% |
| 2021-12-31 | $0.12 B | 156.2% |
| 2020-12-31 | $48.22 M | 0.94% |
| 2019-12-31 | $47.77 M | 287.49% |
| 2018-12-31 | $12.32 M | -31.04% |
| 2017-12-31 | $17.87 M | -5.83% |
| 2016-12-31 | $18.98 M | 61.87% |
| 2015-12-31 | $11.72 M | -5.6% |
| 2014-12-31 | $12.42 M | 853.42% |
| 2013-12-31 | $1.3 M | -5.78% |
| 2012-12-31 | $1.38 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -68.82% | 🇺🇸 USA |